NCT02365519View on ClinicalTrials.gov

LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

514

Participants

Timeline

Start Date

March 9, 2015

Primary Completion Date

October 16, 2015

Study Completion Date

October 16, 2015

Conditions
Dry Eye
Interventions
BIOLOGICAL

LME636 ophthalmic solution

BIOLOGICAL

LME636 Vehicle

Inactive ingredients used as a placebo comparator

Sponsors
All Listed Sponsors
collaborator

Novartis Institutes for BioMedical Research

OTHER

lead

Alcon, a Novartis Company

INDUSTRY